These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17576688)

  • 1. SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer.
    Buratti E; Stuani C; De Prato G; Baralle FE
    Nucleic Acids Res; 2007; 35(13):4359-68. PubMed ID: 17576688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12.
    Haque A; Buratti E; Baralle FE
    Nucleic Acids Res; 2010 Jan; 38(2):647-59. PubMed ID: 19910374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
    Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
    J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
    Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
    EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
    Mercado PA; Ayala YM; Romano M; Buratti E; Baralle FE
    Nucleic Acids Res; 2005; 33(18):6000-10. PubMed ID: 16254078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.
    Singh NK; Singh NN; Androphy EJ; Singh RN
    Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
    Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
    Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer.
    Tacke R; Chen Y; Manley JL
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1148-53. PubMed ID: 9037021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
    Dujardin G; Buratti E; Charlet-Berguerand N; Martins de Araujo M; Mbopda A; Le Jossic-Corcos C; Pagani F; Ferec C; Corcos L
    Nucleic Acids Res; 2010 Nov; 38(20):7273-85. PubMed ID: 20631008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter architecture modulates CFTR exon 9 skipping.
    Pagani F; Stuani C; Zuccato E; Kornblihtt AR; Baralle FE
    J Biol Chem; 2003 Jan; 278(3):1511-7. PubMed ID: 12421814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
    Niksic M; Romano M; Buratti E; Pagani F; Baralle FE
    Hum Mol Genet; 1999 Dec; 8(13):2339-49. PubMed ID: 10556281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.